Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing.
Saved in:
| Title: | Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing. |
|---|---|
| Authors: | Kern C; Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital (Bern University Hospital), University of Bern, Bern, Switzerland.; Graduate School for Health Sciences, University of Bern, Bern, Switzerland., Schöning V; Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital (Bern University Hospital), University of Bern, Bern, Switzerland., Chaccour C; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.; Clínica Universidad de Navarra, Pamplona, Spain.; Ifakara Health Institute, Ifakara, Tanzania., Hammann F; Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital (Bern University Hospital), University of Bern, Bern, Switzerland. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2021 Mar 10; Vol. 12, pp. 625678. Date of Electronic Publication: 2021 Mar 10 (Print Publication: 2021). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33776767 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kern+C%22">Kern C</searchLink>; Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital (Bern University Hospital), University of Bern, Bern, Switzerland.; Graduate School for Health Sciences, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schöning+V%22">Schöning V</searchLink>; Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital (Bern University Hospital), University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Chaccour+C%22">Chaccour C</searchLink>; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.; Clínica Universidad de Navarra, Pamplona, Spain.; Ifakara Health Institute, Ifakara, Tanzania.<br /><searchLink fieldCode="AU" term="%22Hammann+F%22">Hammann F</searchLink>; Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital (Bern University Hospital), University of Bern, Bern, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2021 Mar 10; Vol. 12, pp. 625678. <i>Date of Electronic Publication: </i>2021 Mar 10 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33776767 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2021.625678 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 625678 Titles: – TitleFull: Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kern C – PersonEntity: Name: NameFull: Schöning V – PersonEntity: Name: NameFull: Chaccour C – PersonEntity: Name: NameFull: Hammann F IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 03 Text: 2021 Mar 10 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 12 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |